Induction of T-cell apoptosis by Actinobacillus actinomycetemcomitans mutants with deletion ltxA and cdtABC genes: Possible activity of GroEL-like molecule

Oral Microbiology and Immunology

Volumn 18, Issue 6, 2003, Pages 339-349

  Nalbant, A ^a   Chen, C ^a   Wang, Y ^a   Zadeh, Homayoun H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Actinobacillus actinomycetemcomitans; Apoptosis; Cytolethal distending toxin and leukotoxin; T lymphocytes

Indexed keywords

BACTERIAL TOXIN; CHAPERONIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; APOPTOSIS; ARTICLE; BACTERIAL GENE; CDTABC GENE; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; LTXA GENE; MALE; NORMAL HUMAN; T LYMPHOCYTE ACTIVATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANTIBODIES, MONOCLONAL; APOPTOSIS; BACTERIAL TOXINS; CELL CYCLE; CHROMOSOME MAPPING; EXOTOXINS; FEMALE; G2 PHASE; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GROEL PROTEIN; HUMANS; MALE; PROTEIN SUBUNITS; T-LYMPHOCYTES;

EID: 0242473900     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-0055.2003.00082.x     Document Type: Article

References (54)

1. Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001: 69: 5925-5930.
2. Baehni PC, Tsai CC, McArthur WP, Hammond BF, Shenker BJ, Taichman NS. Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol 1981: 26: 671-676.
3. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968: 97 (Suppl): 77-89.
4. Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994: 62: 501-508.
5. Chen Yand Zychlinsky A. Apoptosis induced by bacterial pathogens. Microb Pathog 1994: 17: 203-212.
6. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 2000: 49: 525-534.
7. Cope LD, Lumbley S, Latimer JL, Klesney-Tait J, Stevens MK, Johnson LS, et al. A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA 1997: 94: 4056-4061.
8. Cortes-Bratti X, Chaves-Olarte E, Lagergard T, Thelestam M. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 1999: 103: 107-115.
9. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992: 13: 795-808.
10. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999: 20: 136-167.
11. Gadhavi A, Wilson M, Tabona P, Newman HN, Henderson B, Bennett JH. Inhibition of mitosis and induction of apoptosis in MG63 human osteosarcoma-derived cells in vitro by surface proteins from Actinobacillus actinomycetemcomitans. Arch Oral Biol 2000: 45: 707-711.
12. Gelfanova V, Hansen EJ, Spinola SM. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells. Infect Immun 1999: 67: 6394-6402.
13. Guthmiller JM, Kolodrubetz D, Kraig E. A panel of probes detects DNA polymorphisms in human and non-human primate isolates of a periodontal pathogen, Actinobacillus actinomycetemcomitans. Microb Pathog 1993: 14: 103-115.
14. Kato S, Muro M, Akifusa S, Hanada N, Semba I, Fujii T, et al. Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection. Infect Immun 1995: 63: 3914-3919.
15. Kato S, Nakashima K, Inoue M, Tomioka J, Nonaka K, Nishihara T, et al. Human epithelial cell death caused by Actinobacillus actinomycetemcomitans infection. J Med Microbiol 2000: 49: 739-745.
16. Korostoff J, Wang JF, Kieba I, Miller M, Shenker BJ, Lally ET. Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect Immun 1998: 66: 4474-4483.
17. Korostoff J, Yamaguchi N, Miller M, Kieba I, Lally ET. Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microb Pathog 2000: 29: 267-278.
18. Kurita-Ochiai T, Ochiai K, Fukushima K. Butyric acid-induced apoptosis in Murine thymocytes and splenic T- and B-cells occurs in the absence of p53. J Dent Res 2000: 79: 1948-1954.
19. Lally E, Golub E, Kieba I. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J Biol Chem 1994: 269: 31289-31295.
20. Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J, Rosenbloom JC, et al. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J Biol Chem 1989: 264: 15451-15456.
21. Lally ET, Kieba IR, Demuth DR, Rosenbloom J, Golub EE, Taichman NS, Gibson CW. Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene. Biochem Biophys Res Commun 1989: 159: 256-262.
22. Lewis DA, Stevens MK, Latimer JL, Ward CK, Deng K, Blick R, et al. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC Mutants in in vitro and in vivo systems. Infect Immun 2001: 69: 5626-5634.
23. Li X, Darzynkiewicz Z. Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Prolif 1995: 28: 571-579.
24. Mangan D, Mergenhagen S, Wahl S. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol 1993: 64: 461-466.
25. Mangan D, Taichman N, Lally E, Wahl S. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991: 59: 3267-3272.
26. Nalbant A, Zadeh HH. Evidence for apoptosis of the majority of T cells activated in vitro with Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2000: 15: 290-298.
27. Nalbant A, Zadeh HH. Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway. Oral Microbiol Immunol 2002: 17: 277-284.
28. Ohguchi M, Ishisaki A, Okahashi N, Koide M, Koseki T, Yamato K, et al. Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis. Infect Immun 1998: 66: 5980-5987.
29. Ohta H, Hara H, Fukui K, Kurihara H, Murayama Y, Kato K. Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface. Infect Immun 1993: 61: 4878-4884.
30. Okuda J, Kurazono H, Takeda Y. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog 1995: 18: 167-172.
31. Paju S, Goulhen F, Asikainen S, Grenier D, Mayrand D, Uitto V. Localization of heat shock proteins in clinical Actinobacillus actinomycetemcomitans strains and their effects on epithelial cell proliferation. FEMS Microbiol Lett 2000: 182: 231-235.
32. Peres SY, Marches O, Daigle F, Nougayrede JP, Herault F, Tasca C, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997: 24: 1095-1107.
33. Pickett CL, Cottle DL, Pesci E, CBikah G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 1994: 62: 1046-1051.
34. Pickett CL, Pesci EC, Cottle DL, Russell G, Erdem AN, Zeytin H. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun 1996: 64: 2070-2078.
35. Pickett CL, Whitehouse CA. The cytolethal distending toxin family. Trends Microbiol 1999: 7: 292-297.
36. Poulsen K, Theilade E, Lally ET, Demuth DR, Kilian M. Population structure of Actinobacillus actinomycetemcomitans: a framework for studies of disease-associated properties. Microbiology 1994: 140: 2049-2060.
37. Sato T, Koseki T, Yamato K, Saiki K, Konishi K, Yoshikawa M, et al. p53-Independent expression of p21CIP1/WAF1 in plasmacytic cells during G2 cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect Immun 2002: 70: 528-534.
38. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994: 62: 244-251.
39. Shenker BJ, McArthur W, Tsai C. Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol 1982: 128: 148-154.
40. Shenker BJ, Hoffmaster RH, McKay TL, Demuth DR. Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells. J Immunol 2000: 165: 2612-2618.
41. Shenker BJ, Hoffmaster RH, Zekavat A, Yamaguchi N, Lally ET, Demuth DR. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 2001: 167: 435-441.
42. Shenker BJ, McKay T, Datar S, Miller M, Chowhan R, Demuth DR. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 1999: 162: 4773-4780.
43. Shenker BJ, Tsai CC, Taichman NS. Suppression of lymphocyte responses by Actinobacillus actinomycetemcomitans. J Periodont Res 1982: 17: 462-465.
44. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1982: 15: 606-609.
45. Spitznagel JJ, Kraig E, Kolodrubetz D. Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 1991: 59: 1394-1401.
46. Stevens MK, Latimer JL, Lumbley SR, Ward CK, Cope LD, Lagergard T, Hansen EJ. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. Infect Immun 1999: 67: 3900-3908.
47. Sugai M, Kawamoto T, Peres SY, Ueno Y, Komatsuzawa H, Fujiwara T, et al. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998: 66: 5008-5019.
48. Taichman N, Dean R, Sanderson C. Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 1980: 28: 258-268.
49. van Winkelhoff AJ, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999: 20: 122-135.
50. Wang Y, Goodman S, Redfield R, Casey C. Natural transformation and DNA uptake signal sequences in Actinobacillus actinomycetemcomitans. J Bacteriol 2002: 184: 3442-3449.
51. Wang Y, Taylor DE. A DNA sequence upstream of the tet (O) gene is required for full expression of tetracycline resistance. Antimicrob Agents Chemother 1991: 35: 2020-2025.
52. Whitehouse CA, Balbo PB, Pesci EC, Cottle DL, Mirabito PM, Pickett CL. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect Immun 1998: 66: 1934-1940.
53. Yamamoto S, Mogi M, Kinpara K, Ishihara Y, Ueda N, Amano K, et al. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. J Dent Res 1999: 78: 1230-1237.
54. Zadeh HH, Nalbant A, Park K. Large-scale early in vitro response to Actinobacillus actinomycetemcomitans suggests superantigenic activation of T-cells. J Dent Res 2001: 80: 356-362.